Literature DB >> 28039417

Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?

Elaine M Dennison1, Karen A Jameson1, Jonathan Marks2, Kath Watson3, Kimme Hyrich3,4, Deborah Symmons3,4, Cyrus Cooper5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28039417      PMCID： PMC5401627          DOI： 10.1093/rheumatology/kew466

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients.

Authors:  Li-Hao Chu; Cecilia Portugal; Aniket A Kawatkar; William Stohl; Michael B Nichol
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

2.  Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study.

Authors:  Elizabeth V Arkema; Martin Neovius; Joel K Joelsson; Julia F Simard; Ronald F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2012-04-13       Impact factor: 19.103

3.  Understanding why rheumatoid arthritis patient treatment preferences differ by race.

Authors:  Florina Constantinescu; Suzanne Goucher; Arthur Weinstein; Wally Smith; Liana Fraenkel
Journal:  Arthritis Rheum       Date:  2009-04-15

4.  The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.

Authors:  David Hägg; Marie Eriksson; Anders Sundström; Marcus Schmitt-Egenolf
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

5.  Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study.

Authors:  Nienke Lesuis; Ragnar Befrits; Filippa Nyberg; Ronald F van Vollenhoven
Journal:  BMC Med       Date:  2012-08-01       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.